Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cerilliant
Farmers Insurance
Fuji
Fish and Richardson
Harvard Business School
Mallinckrodt
Healthtrust
Medtronic
Queensland Health

Generated: July 17, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020857

« Back to Dashboard

NDA 020857 describes COMBIVIR, which is a drug marketed by Viiv Hlthcare and is included in one NDA. It is available from five suppliers. Additional details are available on the COMBIVIR profile page.

The generic ingredient in COMBIVIR is lamivudine; zidovudine. There are twenty-eight drug master file entries for this compound. Twenty-four suppliers are listed for this compound. Additional details are available on the lamivudine; zidovudine profile page.
Summary for 020857
Tradename:COMBIVIR
Applicant:Viiv Hlthcare
Ingredient:lamivudine; zidovudine
Patents:0
Therapeutic Class:Antivirals
Formulation / Manufacturing:see details
Pharmacology for NDA: 020857
Suppliers and Packaging for NDA: 020857
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
COMBIVIR lamivudine; zidovudine TABLET;ORAL 020857 NDA Rebel Distributors Corp 21695-846 E 21695-846-06
COMBIVIR lamivudine; zidovudine TABLET;ORAL 020857 NDA ViiV Healthcare Company 49702-202 N 49702-202-18

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength150MG;300MG
Approval Date:Sep 26, 1997TE:ABRLD:Yes

Expired US Patents for NDA 020857

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Viiv Hlthcare COMBIVIR lamivudine; zidovudine TABLET;ORAL 020857-001 Sep 26, 1997 ➤ Sign Up ➤ Sign Up
Viiv Hlthcare COMBIVIR lamivudine; zidovudine TABLET;ORAL 020857-001 Sep 26, 1997 ➤ Sign Up ➤ Sign Up
Viiv Hlthcare COMBIVIR lamivudine; zidovudine TABLET;ORAL 020857-001 Sep 26, 1997 ➤ Sign Up ➤ Sign Up
Viiv Hlthcare COMBIVIR lamivudine; zidovudine TABLET;ORAL 020857-001 Sep 26, 1997 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Citi
McKinsey
Daiichi Sankyo
Deloitte
Baxter
McKesson
Federal Trade Commission
Healthtrust
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.